Evidence map›Paper›PMID 30356220›Full record

ArticleNature2018

Gene expression variability across cells and species shapes innate immunity.

Tzachi Hagai, Xi Chen, Ricardo J Miragaia, Raghd Rostom, Tomás Gomes, Natalia Kunowska, Johan Henriksson, Jong-Eun Park, Valentina Proserpio, Giacomo Donati and 13 more

Abstract readComparative Study
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 147 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Tzachi HagaiWellcome Sanger Institute, Cambridge, UK. tzachi@ebi.ac.uk.
Xi ChenWellcome Sanger Institute, Cambridge, UK.
Ricardo J MiragaiaWellcome Sanger Institute, Cambridge, UK.
Raghd RostomWellcome Sanger Institute, Cambridge, UK.
Tomás GomesWellcome Sanger Institute, Cambridge, UK.
Natalia KunowskaWellcome Sanger Institute, Cambridge, UK.
Johan HenrikssonWellcome Sanger Institute, Cambridge, UK.
Jong-Eun ParkWellcome Sanger Institute, Cambridge, UK.
Valentina ProserpioDepartment of Life Sciences and Systems Biology, University of Turin, Torino, Italy.
Giacomo DonatiDepartment of Life Sciences and Systems Biology, University of Turin, Torino, Italy.
Lara Bossini-CastilloWellcome Sanger Institute, Cambridge, UK.
Felipe A Vieira BragaWellcome Sanger Institute, Cambridge, UK.
Guy NaamatiEMBL- European Bioinformatics Institute, Cambridge, UK.
James FletcherInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Emily StephensonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Peter VeghInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Gosia TrynkaWellcome Sanger Institute, Cambridge, UK.
Ivanela KondovaDivision of Pathology and Microbiology, Animal Science Department, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Mike DennisResearch Department, Public Health England, National Infection Service, Porton Down, UK.
Muzlifah HaniffaInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Armita NourmohammadMax Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Michael LässigInstitute for Biological Physics, University of Cologne, Cologne, Germany.
Sarah A TeichmannWellcome Sanger Institute, Cambridge, UK. st9@sanger.ac.uk.

Funding

Medical Research Council MR/N014995/1
6 · The paper itself

Abstract

As the first line of defence against pathogens, cells mount an innate immune response, which varies widely from cell to cell. The response must be potent but carefully controlled to avoid self-damage. How these constraints have shaped the evolution of innate immunity remains poorly understood. Here we characterize the innate immune response's transcriptional divergence between species and variability in expression among cells. Using bulk and single-cell transcriptomics in fibroblasts and mononuclear phagocytes from different species, challenged with immune stimuli, we map the architecture of the innate immune response. Transcriptionally diverging genes, including those that encode cytokines and chemokines, vary across cells and have distinct promoter structures. Conversely, genes that are involved in the regulation of this response, such as those that encode transcription factors and kinases, are conserved between species and display low cell-to-cell variability in expression. We suggest that this expression pattern, which is observed across species and conditions, has evolved as a mechanism for fine-tuned regulation to achieve an effective but balanced response.

Indexed as

Evolution, MolecularSpecies SpecificityAnimalsCellsCytokinesHumansImmunity, InnateOrgan SpecificityPromoter Regions, GeneticTranscription, GeneticCytokines

Identifiers

PMID30356220
PMCPMC6347972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.